Verily Health Inc Raises $300 Million From Series X Capital Alphabet UCHealth And University Of Colorado

Verily Health Inc. has raised $300 million in a funding round that involved restructuring to eliminate Alphabet’s controlling stake. The transaction was led by Series X Capital, with participation from Alphabet, UCHealth, and the University of Colorado Anschutz. This investment will advance Verily's AI-native precision health platform, which is aimed at integrating fragmented healthcare data and enhancing clinical workflows.

Summary of transaction details:

• Deal Type: Investment
• Transaction Amount: $300,000,000
• Company Name: Verily Health Inc.
• Headquarters: Dallas, Texas
• Key Executive: Stephen Gillett, Chairman and CEO
• Founder's Name: Andy Conrad
• Notable Investors: Series X Capital, Alphabet, UCHealth, University of Colorado Anschutz

Verily, initially developed within Google's X moonshot lab, is focused on creating innovative healthcare solutions by leveraging data and artificial intelligence. Partnerships with Samsung will utilize Galaxy Watch data for biomarker development, while a collaboration with Salesforce aims to enhance the integration of its Pre platform with Agentforce Health, marking advancements in its AI-driven healthcare offerings.